![]() |
市場調查報告書
商品編碼
1503377
至 2030 年血管內超音波設備市場預測 - 按產品、模式、應用、最終用戶和地理位置進行的全球分析Intravascular Ultrasound Devices Market Forecasts to 2030 - Global Analysis By Product, Modality, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球血管內超音波 (IVUS) 設備市場規模為 25.9 億美元,預計到 2030 年將達到 45.2 億美元,預測期內複合年成長率為 7.1%。血管內超音波 (IVUS) 設備是在心導管插入術過程中使用的醫療儀器,可提供血管內部的詳細影像。這些設備利用連接到插入血管的導管上的微型探針發出的高頻聲波。 IVUS 可以即時顯示血管壁、檢測斑塊積聚、評估血管尺寸並幫助制定治療計劃。 IVUS 幫助心臟科醫師就支架置入術、斑塊旋切術或其他干預措施做出明智的決定,以改善患者的治療效果。
根據美國疾病管制與預防中心 (CDC) 的數據,每年約有 805,000 名美國人患有心臟病;其中 605,000 例心臟病是首次發作,20 萬例發生在已經經歷過心臟病的人中,五分之一的心臟病發作是無症狀的。
心血管疾病發生率不斷上升
IVUS 設備透過提供血管內部的詳細影像,在診斷和管理心血管疾病方面發揮著至關重要的作用。 IVUS 技術能夠精確評估斑塊形成和動脈尺寸,有助於做出準確的治療決策並改善患者的治療效果。隨著醫療保健提供者越來越重視心血管疾病的早期檢測和干涉,在技術進步和醫療保健專業人員意識不斷提高的推動下,IVUS 設備市場持續擴大。
報銷政策不一致
由於不同地區或醫療保健系統的法規和標準不同,血管內超音波 (IVUS) 設備的報銷政策不一致。這些不一致給醫療保健提供者帶來了報銷資格和費率方面的不確定性,可能會阻礙對 IVUS 技術的投資。如果沒有明確的經濟誘因,供應商可能會猶豫是否採用 IVUS 設備,從而限制了市場擴張。
擴大醫療基礎設施
擴大醫療基礎設施可促進先進醫療技術的普及,從而支持血管內超音波 (IVUS) 設備市場的成長。改善的醫療設施使更多的醫院和診所能夠採用 IVUS 設備,從而提高診斷能力和患者治療效果。此外,基礎設施擴張包括增加醫療保健專業人員的培訓機會,從而提高 IVUS 技術的採用率。
昂貴的 IVUS 設備和程序
IVUS 設備和程序的高成本阻礙了市場成長,這主要是由於醫療保健提供者和患者面臨的財務限制。購買 IVUS 設備所需的初始投資龐大,限制了其採用,特別是在資源有限的地區。此外,IVUS 手術的費用可能會讓患者望而卻步,從而減少了需求。這些因素限制了先進診斷能力和創新治療方案的取得,從而阻礙了市場擴張。
Covid-19 影響
由於醫療資源被轉移來應對危機,covid-19 大流行對血管內超音波 (IVUS) 設備市場產生了重大影響。選擇性手術(包括使用 IVUS 的手術)被推遲或取消,導致設備利用率和銷售下降。然而,隨著醫療保健系統適應並恢復擇期手術,IVUS 需求開始復甦,這得益於其在心血管診斷和治療計劃中的重要作用。隨著醫療服務逐漸恢復正常,市場可望發展穩定。
IVUS 導管領域預計將在預測期內成為最大的領域
IVUS 導管領域預計將出現利潤豐厚的成長。 IVUS 導管是用於可視化和評估血管內部的醫療設備。它們利用高頻聲波產生血管壁的詳細影像,為臨床醫生提供有關動脈粥狀硬化程度、斑塊形態和血管尺寸的重要見解。 IVUS 導管在指導血管成形術和支架置入等介入手術中發揮關鍵作用,透過直接從動脈內精確評估血管病理學來幫助最佳化治療結果。
預計周邊血管成像領域在預測期內的複合年成長率最高
預計周邊血管成像領域在預測期內將出現最快的複合年成長率。 IVUS 設備在周邊血管成像中發揮重要作用,有助於血管內部的高解析度可視化。這些設備利用聲波產生詳細的橫斷面影像,有助於評估血管形態、斑塊成分和狹窄嚴重程度。 IVUS 設備可即時了解血管結構和病理學。
在亞太地區,心血管疾病盛行率增加、醫療基礎設施改善和醫療支出增加推動血管內超音波 (IVUS) 設備市場不斷成長。中國、日本和印度等國家因其龐大的患者群體和不斷擴大的醫療服務而成為這一成長的主要貢獻者。此外,技術進步和微創手術的廣泛採用正在提高 IVUS 設備的利用率。
在北美,血管內超音波 (IVUS) 設備市場十分成熟,其特點是先進的醫療基礎設施、創新醫療技術的高採用率以及研發方面的大量投資。美國由於其龐大的患者群體、強勁的醫療保健支出以及主要市場參與者的強大影響力而在市場佔有率方面處於領先地位。 IVUS設備廣泛用於心血管疾病的診斷和治療,推動市場成長。
2024 年 5 月,Provisio Medical, Inc. 宣布利用 Provisio SLT 血管內超音波 (IVUS) 系統完成了首個商業臨床案例。有慢性和肢體威脅性缺血的患者的適當治療至關重要。
2023 年 10 月,Evident Vascular 推出了經導管 IVUS,並獲得了 Vensana Capital 的 3,500 萬美元 A 輪融資,用於開發血管內超音波 (IVUS) 平台。它旨在捕捉血管內部的圖像,以評估血管疾病並指導介入治療。
According to Stratistics MRC, the Global Intravascular Ultrasound (IVUS) Devices Market is accounted for $2.59 billion in 2024 and is expected to reach $4.52 billion by 2030 growing at a CAGR of 7.1% during the forecast period. Intravascular ultrasound (IVUS) devices are medical instruments used during cardiac catheterization procedures to provide detailed images of blood vessel interiors. These devices utilize high-frequency sound waves emitted from a tiny probe attached to a catheter, which is inserted into the blood vessel. IVUS enables real-time visualization of the vessel walls, detecting plaque buildup, assessing vessel dimensions, and aiding in treatment planning. IVUS helps cardiologists make informed decisions regarding stenting, atherectomy, or other interventions to improve patient outcomes.
According to the Centers for Disease Control and Prevention (CDC), each year, about 805,000 Americans experience a heart attack; 605,000 of those heart attacks are the first ones and 200,000 occur in individuals who have already experienced one, and 1 in 5 heart attacks are silent.
Growing incidenceof cardiovascular diseases
IVUS devices play a crucial role in diagnosing and managing cardiovascular conditions by providing detailed imaging of blood vessels from within. IVUS technology enables precise assessment of plaque buildup and artery dimensions, aiding in accurate treatment decisions and improving patient outcomes. As healthcare providers increasingly prioritize early detection and intervention for cardiovascular diseases, the IVUS devices market continues to expand, driven by advancements in technology and rising awareness among healthcare professionals.
Inconsistent reimbursement policies
Inconsistent reimbursement policies in intravascular ultrasound (IVUS) devices arise due to varying regulations and criteria across different regions or healthcare systems. These inconsistencies create uncertainty for healthcare providers regarding reimbursement eligibility and rates, potentially deterring investment in IVUS technology. Providers may hesitate to adopt IVUS devices without clear financial incentives, limiting market expansion.
Expanding healthcare infrastructure
Expanding healthcare infrastructure supports the growth of the intravascular ultrasound (IVUS) devices market by facilitating greater accessibility to advanced medical technologies. Improved healthcare facilities enable more hospitals and clinics to adopt IVUS devices, enhancing diagnostic capabilities and patient outcomes. Additionally, infrastructure expansion includes increased training opportunities for healthcare professionals, boosting the adoption rate of IVUS technology.
Expensive IVUS equipment and procedures
The high cost of IVUS equipment and procedures hampers market growth primarily due to financial constraints faced by healthcare providers and patients. The initial investment required for purchasing IVUS equipment is substantial, limiting adoption, especially in resource-constrained regions. Moreover, the cost of IVUS procedures can be prohibitive for patients, reducing demand. These factors hinder market expansion by restricting access to advanced diagnostic capabilities and innovative treatment options.
Covid-19 Impact
The covid-19 pandemic significantly impacted the intravascular ultrasound (IVUS) devices market as healthcare resources were diverted to manage the crisis. Elective procedures, including those using IVUS, were postponed or cancelled, leading to a decline in device utilization and sales. However, as healthcare systems adapted and resumed elective surgeries, IVUS demand began recovering, driven by its essential role in cardiovascular diagnostics and treatment planning. The market is expected to stabilize as healthcare services gradually return to normalcy.
The IVUS catheters segment is expected to be the largest during the forecast period
The IVUS catheters segment is estimated to have a lucrative growth. IVUS catheters are medical devices used to visualize and assess the interior of blood vessels. They employ high-frequency sound waves to generate detailed images of vessel walls, providing clinicians with crucial insights into the extent of atherosclerosis, plaque morphology, and vessel dimensions. IVUS catheters play a pivotal role in guiding interventional procedures like angioplasty and stent placement, helping to optimize treatment outcomes by enabling precise assessment of vessel pathology directly from within the artery.
The peripheral vascular imaging segment is expected to have the highest CAGR during the forecast period
The peripheral vascular imaging segment is anticipated to witness the fastest CAGR growth during the forecast period. IVUS devices are instrumental in peripheral vascular imaging, facilitating high-resolution visualization of blood vessel interiors. These devices utilize sound waves to produce detailed cross-sectional images, aiding in the assessment of vessel morphology, plaque composition, and stenosis severity. IVUS devices offer real-time insights into vessel structure and pathology.
In the Asia-Pacific region, the Intravascular Ultrasound (IVUS) Devices market is experiencing growth driven by increasing cardiovascular disease prevalence, improving healthcare infrastructure, and rising healthcare expenditure. Countries like China, Japan, and India are key contributors to this growth due to their large patient populations and expanding healthcare access. Additionally, technological advancements and greater adoption of minimally invasive procedures are boosting IVUS device utilization.
In North America, the Intravascular Ultrasound (IVUS) Devices market is well-established and characterized by advanced healthcare infrastructure, high adoption rates of innovative medical technologies, and significant investments in research and development. The United States leads in market share due to its large patient population, robust healthcare spending, and strong presence of key market players. IVUS devices are widely used in the diagnosis and treatment of cardiovascular diseases, driving market growth.
Key players in the market
Some of the key players profiled in the Intravascular Ultrasound (IVUS) Devices Market include Boston Scientific Corporation, Philips Healthcare, Abbott Laboratories, Terumo Corporation, Siemens Healthineers, Medtronic plc, GE Healthcare, Provisio Medical Inc., Avinger Inc., Infraredx Inc., Evident Vascular, Nipro Corporation, Koninklijke Philips N.V., Samsung Medison, Esaote SpA, Volcano Corporation
In May 2024, Provisio Medical, Inc., announced the completion of the first commercial clinical cases utilizing the Provisio SLT intravascular ultrasound (IVUS) system.It gives rapid, novel, and extremely precise way to get the size and contour of vessels, which is critical for the appropriate treatment of a patient with chronic and limb threatening ischemia.
In October2023, Evident Vascular has launched IVUS transcatheterwith $35m in Series A financing from Vensana Capital for the development of an intravascular ultrasound (IVUS) platform. It is designed to capture images from inside blood vessels to assess vascular disease and guide interventional treatment.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.